Contraindicated use of cisapride: impact of food and drug administration regulatory action.

MLA

Smalley, W., et al. “Contraindicated Use of Cisapride: Impact of Food and Drug Administration Regulatory Action.” JAMA, vol. 284, no. 23, Dec. 2000, pp. 3036–39. EBSCOhost, https://doi.org/10.1001/jama.284.23.3036.

APA

Smalley, W., Shatin, D., Wysowski, D. K., Gurwitz, J., Andrade, S. E., Goodman, M., Chan, K. A., Platt, R., Schech, S. D., & Ray, W. A. (2000). Contraindicated use of cisapride: impact of food and drug administration regulatory action. JAMA, 284(23), 3036–3039. https://doi.org/10.1001/jama.284.23.3036

Chicago

Smalley, W, D Shatin, D K Wysowski, J Gurwitz, S E Andrade, M Goodman, K A Chan, R Platt, S D Schech, and W A Ray. 2000. “Contraindicated Use of Cisapride: Impact of Food and Drug Administration Regulatory Action.” JAMA 284 (23): 3036–39. doi:10.1001/jama.284.23.3036.